GE, Siemens MRIs focus of FDA recalls

The FDA has issued separate Class II recalls for MRI systems from GE Healthcare and Siemens.

The GE recall is related to software updates for certain Signa, Discovery and Optima systems. “GE Healthcare has become aware of a potential safety issue involving MRI systems due to software versions not being maintained properly at some sites,” wrote the FDA.

The GE recall affects more than 9,000 installed systems worldwide, including nearly 3,000 in the U.S. The company sent a letter to affected customers earlier this month to describe the issue and how to correct it. Those with additional questions were directed to contact a local service representative.

The Siemens recall notice was regarding Magnetom MRI systems in which gradient output supervision was permanently disabled. As with the GE recall, Siemens customers received a letter informing them of the issue. A total of 132 installed systems are affected, according to the FDA.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.